Select audience

Choose the option that best describes your role.

Search British Business Bank
Popular Search placeholder

British Business Bank invests £8.5 million in Dexory

Press release 26 March 2026

The British Business Bank has invested £8.5 million in Dexory, a leading provider of real-time warehouse intelligence, visibility and autonomous solutions, as part of its recent Series C funding round. 

The round was led by Eurazeo with participation from LTS Growth and Endeavor Catalyst, alongside existing investors Atomico, DTCP, Latitude Ventures, Lakestar, Elaia, Wave-X and others. 

Dexory is a full stack business using autonomous robots to scan warehouses, feeding data into its AI-powered digital twin platform, DexoryView, to give supply chain and logistics companies full visibility of their operations. This allows them to track stock levels, reduce errors and optimise space utilisation.  

The platform is underpinned by intelligence from its global operational data, including more than a billion warehouse location scans, the largest pool of live warehouse data and insights. The technology is used by logistics leaders such as GXO, Maersk, NFI, C.H. Robinson and DHL; manufacturers including Samsung, Stellantis and GE Appliances; and by customers across pharmaceuticals, retail and eCommerce.

Since its Series B, Dexory has expanded its reach across Europe, North America, and APAC, and established its North American headquarters in Nashville, Tennessee. The new funding will accelerate Dexory’s product roadmap and expand access to its technology to multiple international markets and new sectors. 

Leandros Kalisperas, Chief Investment Officer at British Business Bank, said,

The UK consistently produces companies with market-leading technology, which need greater domestic backing to scale globally. The Bank is stepping up to ensure companies like Dexory have the capital they need to innovate and expand here in the UK. We are working with fund managers to create deeper pools of capital and are increasing the scale of our co-investing activity, which directly increases the size of funding rounds for high-potential UK companies.

George Mills, Investment Director, British Business Bank, said

Dexory is already delivering tangible value for customers, but it has clear potential to scale further. They have an extensive proprietary data set based on over 500 million warehouse locations, which continuously strengthens the AI model. This gives the company a first mover advantage in technology that could significantly improve logistics and supply chains, which underpin global trade and commerce.

Andrei Danescu, CEO and Co-Founder of Dexory, said

We’re proud to have the support of the British Business Bank as we accelerate our expansion into global markets. Our focus has always been on delivering tangible value through real-time visibility, powered by one of the industry’s largest and most dynamic operational datasets. This investment enables us to advance our technology and support more organisations in building smarter, more resilient supply chains.

Further Information

If you are a journalist and have a media enquiry, please contact [email protected].

Notes to editors

About British Business Bank 

The British Business Bank is the UK government’s economic development bank. Established in November 2014, its mission is to drive economic growth by helping smaller businesses get the finance they need to start, scale and stay in the UK. In doing so, we help capture the economic value of innovation for the UK and create jobs and prosperity for people across the country. 

The British Business Bank’s core programmes support £23bn 1  of finance to almost 64,000 2  smaller businesses.

British Business Bank plc is a public limited company registered in England and Wales, registration number 08616013, registered office at Steel City House, West Street, Sheffield, S1 2GQ. It is a development bank wholly owned by HM Government. British Business Bank plc and its subsidiaries are not banking institutions and do not operate as such. With the exception of BBB Investment Services Limited they are not authorised or regulated by the Prudential Regulation Authority or the Financial Conduct Authority. BBB Investment Services Limited is authorised and regulated by the Financial Conduct Authority. A complete legal structure chart for the group can be found at british-business-bank.co.uk.

The above investment is operated by British Patient Capital Limited, a wholly owned commercial subsidiary of British Business Bank plc. British Patient Capital Limited is registered in England and Wales with company number 11271076, and registered office at Steel City House, West Street, Sheffield, S1 2GQ. British Patient Capital makes commitments and invests on its own behalf and on behalf of third-party investors whose investments British Patient Capital manages.

The transaction described above does not constitute or imply any endorsement, warranty or recommendation by the UK government, the British Business Bank plc, its subsidiaries or any other party in respect of Dexory or its products or services.

About Dexory 

Dexory delivers a data intelligence platform that transforms warehouse visibility with unprecedented speed and impact. By combining autonomous robots, AI and digital twin technology, DexoryView provides warehouse and supply chain operators with full operational visibility and real-time insights from day one, unlocking value far faster than conventional solutions.

Designed to integrate seamlessly with autonomous, hybrid, and manual operations, DexoryView doesn’t replace existing systems - it elevates them, improving the quality and effectiveness of processes already in place. This speed to market, paired with the depth of Dexory’s technology, gives businesses a unique advantage in optimising the present, de-risking the future, and uncovering opportunities across every stage of the product journey. The platform is used by logistics leaders such as GXO, Maersk and DHL amongst many others; manufacturers including Stellantis and GE Appliances; and customers across pharmaceuticals, retail, and e-commerce.

Quick links

Latest news